Levy Raphi 4

What Happened

• Levy Raphi, Chief Financial Officer of Alpha Tau Medical Ltd. (DRTS), exercised 2,127 derivative securities (code M) on July 1, 2026 at an exercise price of $2.98 per share (cost $6,338). The same day he sold those 2,127 shares in an open-market transaction (code S) at $13.02 per share for total proceeds of $27,691. This sequence is an exercise followed by an immediate sale (commonly a cashless exercise); sales are often routine liquidity or tax-related transactions and do not by themselves indicate company outlook.

Key Details

• Transaction date: 2026-07-01
• Exercise: 2,127 shares @ $2.98 each = $6,338 (code M)
• Sale: 2,127 shares @ $13.02 each = $27,691 (code S)
• Net pre-tax gain on the round trip: ~$21,353 (proceeds minus exercise cost), not accounting for fees or taxes
• Shares owned after the transaction: not provided in the supplied filing data
• Filing: Form 4 filed 2026-07-02 (appears timely based on the reported dates)
• No footnotes, 10b5-1 plan, or special withholding noted in the provided information

Context

• This was an option exercise immediately followed by a sale of all shares acquired in the exercise — a common mechanism to cover exercise cost and taxes while realizing any spread between exercise price and market price. Such transactions are factual disclosures of insider activity; they should be considered alongside other filings and company news rather than as standalone indicators of management sentiment.